Treatment with rosuvastatin for severe dyslipidaemia in patients with schizophrenia and Schizoaffective disorder

被引：0
|
作者：
De Hert, M.
Kalnicka, D.
van Winkel, R.
Wampers, M.
Hanssens, L.
Van Eyck, D.
Scheen, A.
Peuskens, J.
机构：
[1] Katholieke Univ Leuven, Ctr Psychiat, Kortenberg, Belgium
[2] Charles Univ Prague, Dept Psychiat, Med Fac Hradec, Kralove, Czech Republic
[3] Univ Liege, Dept Epidemiol & Publ Hlth, Liege, Belgium
[4] Univ Liege, Dept Diabet Nutr & Metab Disorders, CHU Sart Tilman, Liege, Belgium
来源：
DRUG SAFETY | 2006年 / 29卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
178
引用
收藏
页码：1002 / 1002
页数：1
相关论文
共 50 条
  • [41] Improvement of comorbid depression with olanzapine versus ziprasidone treatment in patients with schizophrenia or schizoaffective disorder
    Kinon, B
    Lipkovich, I
    Edwards, S
    Hill, A
    Ahl, J
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 163 - 163
  • [42] Combined clozapine-lithium treatment in schizophrenia and schizoaffective disorder
    Moldavsky, M
    Stein, D
    Benatove, R
    Sirota, P
    Weizman, A
    Elizur, A
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : VA10 - VA10
  • [43] KNOWLEDGE OF THE TREATMENT IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER AND ITS RELATIONSHIP WITH NONADHERENCE
    Acosta, Francisco J.
    Vega, Dulcinea
    Saavedra, Pedro
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2023, 51 (04): : 157 - 166
  • [44] CLOZAPINE IN THE TREATMENT OF PSYCHOTIC MOOD DISORDERS, SCHIZOAFFECTIVE DISORDER, AND SCHIZOPHRENIA
    MCELROY, SL
    DESSAIN, EC
    POPE, HG
    COLE, JO
    KECK, PE
    FRANKENBERG, FR
    AIZLEY, HG
    OBRIEN, S
    JOURNAL OF CLINICAL PSYCHIATRY, 1991, 52 (10) : 411 - 414
  • [45] CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder
    Sharma, RP
    Janicak, PG
    Bissette, G
    Nemeroff, CB
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (07): : 1019 - 1021
  • [46] Pharmacological treatment of schizophrenia and schizoaffective disorder - focused on combinations of antipsychotics
    Ustohal, L.
    Prikryl, R.
    Kucerova, H. Prikrylova
    Vrzalova, M.
    Kasparek, T.
    Ceskova, E.
    Stehnova, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 138 - 139
  • [47] Combined clozapine-lithium treatment for schizophrenia and schizoaffective disorder
    Moldavsky, M
    Stein, D
    Benatov, R
    Sirota, P
    Elizur, A
    Matzner, Y
    Weizman, A
    EUROPEAN PSYCHIATRY, 1998, 13 (02) : 104 - 106
  • [48] Physiology of schizophrenia, bipolar disorder, and Schizoaffective disorder
    Martin, Laura F.
    Hall, Mei-Hua
    Ross, Randal G.
    Zerbe, Gary
    Freedman, Robert
    Olincy, Ann
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (12): : 1900 - 1906
  • [49] Treatment-emergent tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia or schizoaffective disorder
    Miller, D. D.
    Kim, E.
    Eudicone, J.
    Pikalov, A.
    Vester-Blokland, E.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 503 - 503
  • [50] Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia
    Davidson, MH
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (01) : 125 - 141
12345